• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉导管未闭的非药物治疗。

Non-pharmacological management of a hemodynamically significant patent ductus arteriosus.

机构信息

Department of Neonatology, The Rotunda Hospital, Dublin, Ireland.

Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada; Physiology and Experimental Medicine Program, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.

出版信息

Semin Fetal Neonatal Med. 2018 Aug;23(4):245-249. doi: 10.1016/j.siny.2018.03.008. Epub 2018 Mar 16.

DOI:10.1016/j.siny.2018.03.008
PMID:29580939
Abstract

The association between the patent ductus arteriosus (PDA) and neonatal morbidity, mortality and poor neurodevelopmental outcome in later childhood has been the focus of intense debate for decades. The lack of evidence supporting therapeutic strategies aimed at achieving PDA closure has led to the widespread adoption of conservative management aimed at mitigating the impact of shunt volume without achieving ductal closure. In this article, we review this management approach, describe the supportive evidence and potential complications associated with this strategy.

摘要

动脉导管未闭(PDA)与新生儿发病率、死亡率和儿童后期神经发育不良结局之间的关系几十年来一直是激烈争论的焦点。缺乏支持旨在实现 PDA 关闭的治疗策略的证据导致广泛采用保守管理策略,旨在减轻分流体积的影响而不实现导管关闭。在本文中,我们回顾了这种管理方法,描述了支持这种策略的证据和潜在并发症。

相似文献

1
Non-pharmacological management of a hemodynamically significant patent ductus arteriosus.动脉导管未闭的非药物治疗。
Semin Fetal Neonatal Med. 2018 Aug;23(4):245-249. doi: 10.1016/j.siny.2018.03.008. Epub 2018 Mar 16.
2
Safety of Conservative Approach for Persistent Patent Ductus Arteriosus in Preterm Infants: Neurodevelopmental Outcomes at 5 Years of Age.保守治疗早产儿持续性动脉导管未闭的安全性:5 岁时的神经发育结局。
Tohoku J Exp Med. 2019 Nov;249(3):155-161. doi: 10.1620/tjem.249.155.
3
Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia.血流动力学显著的动脉导管未闭与支气管肺发育不良的发生
Congenit Heart Dis. 2019 Jan;14(1):27-32. doi: 10.1111/chd.12691. Epub 2018 Oct 20.
4
Diagnosis, Evaluation, and Management of Patent Ductus Arteriosus in Preterm Neonates.早产儿动脉导管未闭的诊断、评估和管理。
JAMA Pediatr. 2015 Sep;169(9):863-72. doi: 10.1001/jamapediatrics.2015.0987.
5
Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.使用Amplatzer动脉导管封堵器额外尺寸-ADOIIAS对32例早产儿血流动力学显著的动脉导管未闭进行经导管封堵术。
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):612-617. doi: 10.1002/ccd.27091. Epub 2017 May 4.
6
Patent Ductus Arteriosus in Preterm Infants, Part 1: Understanding the Pathophysiologic Link Between the Patent Ductus Arteriosus and Clinical Complications.早产儿动脉导管未闭,第1部分:理解动脉导管未闭与临床并发症之间的病理生理联系。
Neonatal Netw. 2017 Sep 1;36(5):265-272. doi: 10.1891/0730-0832.36.5.265.
7
Patent ductus arteriosus and cerebral, cardiac, and gut hemodynamics in premature neonates.动脉导管未闭与早产儿脑、心、肠道血流动力学。
Semin Fetal Neonatal Med. 2020 Oct;25(5):101120. doi: 10.1016/j.siny.2020.101120. Epub 2020 Jun 2.
8
Hemodynamic assessment of the patent ductus arteriosus: Beyond ultrasound.动脉导管未闭的血流动力学评估:超越超声。
Semin Fetal Neonatal Med. 2018 Aug;23(4):239-244. doi: 10.1016/j.siny.2018.04.002. Epub 2018 Apr 27.
9
Catheter-based closure of the patent ductus arteriosus in lower weight infants.经导管动脉导管未闭封堵术在低体重婴儿中的应用。
Semin Perinatol. 2018 Jun;42(4):262-268. doi: 10.1053/j.semperi.2018.05.009. Epub 2018 Jun 13.
10
International perspective on management of a patent ductus arteriosus: Lessons learned.国际视角下动脉导管未闭的管理:经验教训。
Semin Fetal Neonatal Med. 2018 Aug;23(4):278-284. doi: 10.1016/j.siny.2018.03.002. Epub 2018 Mar 7.

引用本文的文献

1
Perinatal Factors Associated with Successful Pharmacologic Closure of the Patent Ductus Arteriosus in Premature Infants.与早产儿动脉导管未闭药物成功闭合相关的围产期因素
Pediatr Cardiol. 2024 Aug 21. doi: 10.1007/s00246-024-03626-2.
2
Association between Fluid Balance and Treatment Outcome of Ibuprofen for Patent Ductus Arteriosus in Preterm Infants.早产儿动脉导管未闭使用布洛芬治疗时液体平衡与治疗结果之间的关联。
Rev Cardiovasc Med. 2023 Mar 3;24(3):78. doi: 10.31083/j.rcm2403078. eCollection 2023 Mar.
3
Who Still Gets Ligated? Reasons for Persistence of Surgical Ligation of the Patent Ductus Arteriosus Following Availability of Transcatheter Device Occlusion for Premature Neonates.
仍接受结扎手术的是哪些人?在经导管装置可用于早产儿动脉导管未闭封堵后,仍持续进行动脉导管未闭手术结扎的原因。
J Cardiovasc Dev Dis. 2024 Apr 23;11(5):132. doi: 10.3390/jcdd11050132.
4
Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.血流动力学显著的动脉导管未闭早产儿对一线对乙酰氨基酚治疗反应的临床和超声心动图预测因素
J Perinatol. 2024 Mar;44(3):379-387. doi: 10.1038/s41372-024-01883-w. Epub 2024 Jan 31.
5
Nutrition with a patent ductus arteriosus: feast, feed, or famine?患有动脉导管未闭时的营养:充足、喂养还是匮乏?
Pediatr Res. 2023 Oct 19. doi: 10.1038/s41390-023-02861-2.
6
The role of furosemide and fluid management for a hemodynamically significant patent ductus arteriosus in premature infants.速尿及液体管理在早产儿血流动力学显著的动脉导管未闭中的作用
J Perinatol. 2022 Dec;42(12):1703-1707. doi: 10.1038/s41372-022-01450-1. Epub 2022 Jul 15.
7
The patent ductus arteriosus management debate: it's not over yet.动脉导管未闭的治疗争论:尚未结束。
J Perinatol. 2021 May;41(5):923-925. doi: 10.1038/s41372-021-01059-w. Epub 2021 Apr 15.
8
Echocardiographic predictors of acute kidney injury in neonates with a patent ductus arteriosus.超声心动图预测动脉导管未闭新生儿急性肾损伤的指标。
J Perinatol. 2020 Mar;40(3):510-514. doi: 10.1038/s41372-019-0560-1. Epub 2019 Nov 25.
9
Clinical outcomes after more conservative management of patent ductus arteriosus in preterm infants.早产儿动脉导管未闭更保守治疗后的临床结局。
J Pediatr (Rio J). 2020 Mar-Apr;96(2):177-183. doi: 10.1016/j.jped.2018.10.004. Epub 2018 Nov 10.